GlassScriptPhysician profile
Lucas Rich
NPI 1205405909
$568.64
in general payments reported to CMS, 2019-2025
9 companies · $488 in 2025
The $488 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $81.03 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.64 |
| Education | $145.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $165.21 | 2025 | Ensite, Cardiomems |
| Medtronic, INC. | $153.45 | 2025 | Corevalve Evolut R |
| Baxter Healthcare | $85.79 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Irhythm Technologies, INC. | $62.21 | 2024 | Zio Monitor, Zio Xt Patch |
| Astrazeneca Pharmaceuticals LP | $25.82 | 2025 | |
| Bridgebio Pharma, INC. | $24.39 | 2025 | Attruby |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.82 | 2024 | Lifevest |
| Novo Nordisk INC | $18.74 | 2025 | |
| Heartflow, INC. | $14.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucas Rich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.